Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Prager

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
National Cancer Institute Monograph|December 1, 1971
Prediction of response to L-asparaginase therapyM D Prager
Bibliotheca Haematologica|January 1, 1973
Vaccination and immunotherapy with chemically modified cancer cellsM D Prager
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|July 1, 1973
Immunological stimulation with modified cancer cellsM D Prager
Transfusion|March 1, 1970
The nature of Rh blocking antibodiesM D Prager, J Rd
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1971
Metabolism of asparagine, aspartate, glutamine, and glutamate in lymphoid tissue: basis for immunosuppression by L-asparaginaseM D Prager, I Derr
Cancer Chemotherapy Reports|June 1, 1972
Failure of combination therapy with S-carbamyl-L-cysteine (SCC; NSC-102498) and L-asparaginase (NSC-109229) for L-asparaginase-resistant mouse lymphomaM D Prager, L Rothberg
Cancer Research|August 1, 1973
Basis for loss of therapeutic effectiveness of L-asparaginase in sensitized miceS Baechtel, M D Prager
The Journal of Biological Chemistry|July 10, 1981
The effect of butyrate on sulfated glycoprotein biosynthesis by human kidney tumor cellsA Heifetz, M D Prager
Nature|March 7, 1970
Inhibition of primary antibody response by E. coli asparaginaseM D Prager, I Derr
Cancer Research|July 1, 1978
Enhanced response to chemoimmunotherapy and immunoprophylaxis with the use of tumor-associated antigens with a lipophilic agentM D Prager, W C Gordon
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
National Cancer Institute Monograph|December 1, 1971
Prediction of response to L-asparaginase therapyM D Prager
Bibliotheca Haematologica|January 1, 1973
Vaccination and immunotherapy with chemically modified cancer cellsM D Prager
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|July 1, 1973
Immunological stimulation with modified cancer cellsM D Prager
Transfusion|March 1, 1970
The nature of Rh blocking antibodiesM D Prager, J Rd
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1971
Metabolism of asparagine, aspartate, glutamine, and glutamate in lymphoid tissue: basis for immunosuppression by L-asparaginaseM D Prager, I Derr
Cancer Chemotherapy Reports|June 1, 1972
Failure of combination therapy with S-carbamyl-L-cysteine (SCC; NSC-102498) and L-asparaginase (NSC-109229) for L-asparaginase-resistant mouse lymphomaM D Prager, L Rothberg
Cancer Research|August 1, 1973
Basis for loss of therapeutic effectiveness of L-asparaginase in sensitized miceS Baechtel, M D Prager
The Journal of Biological Chemistry|July 10, 1981
The effect of butyrate on sulfated glycoprotein biosynthesis by human kidney tumor cellsA Heifetz, M D Prager
Nature|March 7, 1970
Inhibition of primary antibody response by E. coli asparaginaseM D Prager, I Derr
Cancer Research|July 1, 1978
Enhanced response to chemoimmunotherapy and immunoprophylaxis with the use of tumor-associated antigens with a lipophilic agentM D Prager, W C Gordon
Pageof 5